香港交易所：香港期货交易所有限公司已取得证监会批准，于2025年11月28日推出恒生生物科技指数期货

Core Viewpoint - The Hong Kong Futures Exchange has received approval from the Securities and Futures Commission to launch the Hang Seng Biotechnology Index futures on November 28, 2025 [1] Group 1 - The approval marks a significant development for the Hong Kong Futures Exchange, expanding its product offerings in the biotechnology sector [1] - The introduction of the Hang Seng Biotechnology Index futures is expected to attract more investors and enhance market liquidity [1]